Sudeep Pharma (BOM:544619) Construction In Progress: ₹1,839 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544619 Sudeep Pharma Ltd BOM:544619
18 GF Score
Price ₹868.55
! 5 Warning Signs
View Full Analysis

What is Sudeep Pharma Construction In Progress?

Sudeep Pharma BOM:544619 -1.10% 18 Construction In Progress is ₹1,839 Mil as of Mar. 2026. GuruFocus rates BOM:544619 with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

Sudeep Pharma's quarterly construction in progress declined from Jun. 2025 (₹1,191 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,839 Mil).

Sudeep Pharma's annual construction in progress increased from Mar. 2024 (₹525 Mil) to Mar. 2025 (₹971 Mil) and increased from Mar. 2025 (₹971 Mil) to Mar. 2026 (₹1,839 Mil).

Sudeep Pharma Construction In Progress Historical Data

* Premium members only.

The historical data trend for Sudeep Pharma's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudeep Pharma Construction In Progress Chart

Sudeep Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Construction In Progress
290.78 525.48 971.33 1,839.27

Sudeep Pharma Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial 0.00 971.33 1,190.94 0.00 1,839.27
BOM:544619
18GF Score
Sudeep Pharma Ltd BOM:544619
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sudeep Pharma Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹1,839 Mil mean?
Sudeep Pharma (BOM:544619) has a Construction In Progress of ₹1,839 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Sudeep Pharma and its competitors.
Is Sudeep Pharma's Construction In Progress too high?
Sudeep Pharma's current Construction In Progress is ₹1,839 Mil. Overall, Sudeep Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sudeep Pharma's Construction In Progress compare to ZTS?
Sudeep Pharma's Construction In Progress of ₹1,839 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Sudeep Pharma and its competitors. Sudeep Pharma's current Construction In Progress is ₹1,839 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudeep Pharma stock overvalued right now?
Sudeep Pharma (BOM:544619) has a current Construction In Progress of ₹1,839 Mil. The current Construction In Progress is ₹1,839 Mil. Sudeep Pharma's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Sudeep Pharma (BOM:544619), the current Construction In Progress is ₹1,839 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sudeep Pharma Business Description

Other Exchanges SUDEEPPHRM:India
Address Gotri-Sevasi Road, 601-602, 6th floor, Sears II, East Wing, Towers - 2, Sevasi, Vadodara, GJ, IND, 391101
Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare ecosystem. The company operates in two business verticals: Pharmaceutical, food, and nutrition. It focuses on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries and Specialty ingredients: It pertains manufacturing of specialty ingredients using advance technology solutions. The maximum revenue is generated from the Pharmaceutical, food, and nutrition segment. Geographically, it has presence in the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
18GF Score

Get the complete analysis for BOM:544619

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹868.55
Price